Status | Study |
RECRUITING |
Study Name: Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma Condition: Leiomyosarcoma Date: 2023-09-28 Interventions: Intravenous Infusion |
RECRUITING |
Study Name: Localized Leiomyosarcoma Biomarker Protocol Condition: Leiomyosarcoma Date: 2021-06-08 Interventions: Blood and tissue will be collected and analyzed for detection of ctDNA and genetic change |
Not yet recruiting |
Study Name: Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery Condition: Metastatic Leiomyosarcoma Metastatic Liposarcoma Date: 2017-03-01 Interventions: Drug: Avelumab Given IV |
Not yet recruiting |
Study Name: Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma Condition: Uterine or Soft Tissue Leiomyosarcoma Date: 2016-12-13 Interventions: Drug: Doxorubicin Drug: Trabectedin |
Suspended |
Study Name: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma Condition: Uterine Corpus Leiomyosarcoma Date: 2015-04-23 Interventions: Biological: Ipilimumab Given I |
Withdrawn |
Study Name: Pazopanib for Treating Uterine Leiomyosarcoma Condition: Uterine Leiomyosarcoma Date: 2015-02-17 Interventions: Drug: Pazopanib |
Active, not recruiting |
Study Name: SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma Condition: Metastatic Leiomyosarcoma Date: 2014-11-21 Interventions: Drug: Mocetinostat Drug: Gemcitabine |
Active, not recruiting |
Study Name: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma Condition: Leiomyosarcoma Date: 2014-09-23 Interventions: Drug: gemcitabine + docetaxel |
Recruiting |
Study Name: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma Condition: Liposarcoma Leiomyosarcoma Date: 2014-09-05 Interventions: Drug: Trabectedin Trabectedin administered at a dose of 1.5 mg/m2 - 1.3 mg/m2 (at investigator's discret |
Completed |
Study Name: Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma Condition: Uterus Leiomyosarcoma Soft Tissue Leiomyo Date: 2014-05-05 Interventions: Drug: Doxorubicin 60 mg/m² |